Pharmacovigilance: the responsibility of pharmaceutical companies to protect patients from drug-related harms
| dc.contributor.author | Roux, Leanne | |
| dc.date.accessioned | 2015-05-29T13:17:28Z | |
| dc.date.accessioned | 2024-05-15T07:42:31Z | |
| dc.date.available | 2015-05-29T13:17:28Z | |
| dc.date.available | 2024-05-15T07:42:31Z | |
| dc.date.issued | 2014 | |
| dc.description | >Magister Scientiae - MSc | en_US |
| dc.description.abstract | Healthcare professionals (HCPs) have a primary role to play in the detection, assessment and spontaneous reporting of adverse drug reactions (ADRs). An improvement of their related knowledge, attitude and practice concerning pharmacovigilance and ADR reporting is vital. The objective of the study was to determine whether or not pharmacovigilance training, provided by a Pharmaceutical Company, would improve HCP’s perceptions and adherence to pharmacovigilance and ADR reporting. A quasi-experimental research design was used. A total of 44 HCPs participated in the study. Participants were divided into two groups: an experimental group that received pharmaceutical training intervention; and a control group that did not receive any training. Using a self-administered questionnaire before and after the training intervention assessed the knowledge, attitudes, and practice of pharmacovigilance and ADR reporting displayed amongst the HCPs. | en_US |
| dc.identifier.uri | https://hdl.handle.net/10566/15076 | |
| dc.language.iso | en | en_US |
| dc.publisher | University of the Western Cape | en_US |
| dc.rights.holder | University of the Western Cape | en_US |
| dc.subject | Pharmacovigilance | en_US |
| dc.subject | Healthcare professionals | en_US |
| dc.subject | Adverse drug reaction | en_US |
| dc.title | Pharmacovigilance: the responsibility of pharmaceutical companies to protect patients from drug-related harms | en_US |
| dc.type | Thesis | en_US |